Breakthroughs in Brain Cancer: Dr. Henry Friedman's Innovative Treatments
Because the modified poliovirus binds to a receptor Cd155, which is on all solid tumors except Burkitt's lymphoma...you just have to treat enough of a lesion to get the systemic response going and you've fired up the immune system in an extraordinarily efficient way.
Imagine battling one of the most aggressive brain cancers with a modified virus. In this episode of 'Weekly Infusion', Dr. Drew and Dr. Bruce Heischober sit down with Dr. Henry Friedman, a leading neuro-oncologist from Duke University, to discuss groundbreaking treatments for brain cancers, particularly glioblastoma multiforme (GBM). Dr. Friedman shares how his team is using a modified poliovirus to attack solid tumors, revealing the science behind this revolutionary approach.
He delves into the potential of combining poliovirus therapy with checkpoint inhibitors and the promising role of dendritic cells in immunotherapy. The conversation also touches on the risks associated with radiation therapy and the need for improved diagnosis and treatment of rare brain tumors. Plus, Dr. Friedman highlights the critical importance of training the next generation of medical professionals. This episode, sponsored by Hydralyte and Alliant CSP, is a must-listen for anyone interested in cutting-edge cancer treatments and medical advancements.